A Chart Review Study of Adults With Advanced NSCLC
NCT05207423 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 179
Last updated 2023-02-28
Summary
The main aim is to see how treatment patterns and drugs might improve care for adults with advanced or metastatic NSCLC with epidermal growth factor receptor (EGFR) exon-20 driven mutations. Past medical records will be reviewed. No clinic visits or procedures will be required.
Conditions
- Non-small Cell Lung Cancer (NSCLC)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Study Director · Takeda
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-03
- Primary Completion
- 2023-02-13
- Completion
- 2023-02-13
Countries
- Canada
- France
- Hong Kong
Study Locations
More Related Trials
-
A2R and Ectonucleotidases Expression in Lung Cancer Circulating Tumor Cells
NCT05648188 ·Status: WITHDRAWN
-
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
NCT06617390 ·Status: COMPLETED
-
Study of Episodic Breathlessness in Patients With Lung Cancer or Other Advanced Disease
NCT01138358 ·Status: COMPLETED
-
Retrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung Adenocarcinomas
NCT02891733 ·Status: WITHDRAWN
-
Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC
NCT07250360 ·Status: COMPLETED
-
Multiomics Tumor Evolution Model of NSCLC
NCT05352035 ·Status: RECRUITING
-
Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer
NCT07008742 ·Status: RECRUITING
-
Survival Outcomes of Lung Cancer
NCT03647098 ·Status: RECRUITING
-
Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung Cancer
NCT00503958 ·Status: UNKNOWN
-
Prediction of Response to Treatment With Immunotherapy + Chemotherapy in Non-Small Cell Lung Cancer
NCT04589013 ·Status: COMPLETED
-
PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
NCT05049837 ·Status: RECRUITING
-
Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
NCT07035860 ·Status: NOT_YET_RECRUITING
-
Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)
NCT01279408 ·Status: COMPLETED
-
Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC
NCT05873439 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China
NCT07316062 ·Status: RECRUITING
-
Comprehensive Demographics and Clinical Profile of NSCLC Patients
NCT06725537 ·Status: NOT_YET_RECRUITING
-
Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA
NCT03926260 ·Status: COMPLETED ·Phase: NA
-
Molecular Profiling of Exosomes in Tumor-draining Vein of Early-staged Lung Cancer
NCT04939324 ·Status: UNKNOWN ·Phase: NA
-
Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation
NCT04137718 ·Status: UNKNOWN
-
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
NCT06467383 ·Status: RECRUITING
-
Distribution and Prognostic Impact of Oncogenic Drivers in Metastatic Lung Adenocarcinoma : a Retrospective Monocentric Study in Nancy University Hospital Center
NCT04493827 ·Status: COMPLETED
-
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC
NCT05641870 ·Status: UNKNOWN
-
Analysis of Risk Factors of Postoperative Pulmonary Infection in Patients With Esophageal Cancer
NCT05740852 ·Status: COMPLETED
-
Prospective Multicenter Cohort Study for the Development and Evaluation of Risk Stratification Tools for Lung Cancers and Their Postoperative Recurrences Using Multimodal Clinical, Radiological, Tissue and Longitudinal Biological Phenotyping Among People at Risk of Lung Cancer
NCT07042867 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Individualized Treatment of Patients With Advanced NSCLC: Potential Application for Circulating Tumor Cells (CTC) Molecular and Phenotypical Profiling
NCT02407327 ·Status: COMPLETED